Peptomyc
PrivateLast Round
VC Round
Mar 24, 2024
Total Funding Raised
$24.69M
Company Overview
Peptomyc is a biotechnology company developing a new generation of cell-penetrating peptide therapeutics targeting the MYC oncogene for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptomyc Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Peptomyc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2024 | ||||
| Grant | Oct 31, 2023 | ||||
| Convertible Debt | Jan 20, 2022 | ||||
| VC Round | Dec 15, 2020 | ||||
| Series A | Sep 12, 2019 | ||||
Grant | Jul 30, 2019 |
Key People
Founding team and executive leadership
Peptomyc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Convertible Debt |
| Horizon 2020 | Grant |
| European Innovation Council Fund | VC Round, Grant |
| Alta Life Sciences | VC Round, Convertible Debt, Series A |
| Healthequity SCR | VC Round, Series A, Convertible Debt, Seed |
| Agencia Estatal de Investigación | Debt |
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors grew 266% MoM to 3.1K.
- May 1, 2025
Monthly visitors grew 146% MoM, reaching 2.1K.
Peptomyc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peptomyc's valuation, stock price, and market status.